Azo compounds for type I phototherapy

Details for Australian Patent Application No. 2002307394 (hide)

Owner Mallinckrodt Inc.

Inventors Cantrell, Gary L.; Rajagopalan, Raghavan; Achilefu, Samuel I.; Bugaj, Joseph E.; Dorshow, Richard B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002307394

PCT Number PCT/US02/12217

PCT Pub. Number WO2002/089858

Priority 09/849,163 04.05.01 US

Filing date 18 April 2002

Wipo publication date 18 November 2002

Acceptance publication date 19 April 2007

International Classifications

C07D 491/06 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/7042 (2006.01) - Compounds having saccharide radicals and heterocyclic rings

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61N 5/06 (2006.01) Radiation therapy - using light

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 15/14 (2006.01) Drugs for genital or sexual disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/849,163 04.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002307394

19 April 2007 Application Accepted

  Published as AU-B-2002307394

16 August 2007 Standard Patent Sealed

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307395-INSTANT MESSAGE PROXY FOR CIRCUIT SWITCHED MOBILE ENVIRONMENT

2002307393-INDUCIBLE EXPRESSION OF TRANSFECTED GENES